Our Company

Our Company

Our Team

The entire team from Good Therapeutics has joined Bonum, bringing a tremendous track record of success and a passion for making a difference in the lives of patients.

Leadership

Management Team

JOHN MULLIGAN, PhD

Founder and Chief Executive Officer

DIANE HOLLENBAUGH, PhD

Chief Scientific Officer

NEELA PATEL, PhD

Chief Business Officer

JUSTIN KILLEBREW, PhD

Senior Director, Immuno-Oncology Discovery

DAVID BIENVENUE, PhD

Senior Director, Protein Science

Board of Directors

JOHN MULLIGAN, PhD

Founder and Chief Executive Officer

KARL HANDELSMAN

Founder & Managing Partner, Codon Capital

JOHN MCKEARN, PhD

Managing Director, Rivervest

MONIQUE SCHIERSING, MSc MBA

Senior Investment Director, Roche Venture Fund

NICHOLAS WALROD

Managing Partner, American Century Investments

SAMUEL BJORK

Partner, Digitalis Ventures

MITCHELL MUTZ, PhD

Entrepreneur Partner, Vivo Capital

Our Investors

We are fortunate to have an experienced and engaged group of investors, most of whom also participated in our predecessor company Good Therapeutics, who share our excitement and fully grasp the potential of our technology. They've provided unwavering support and insight, which has been crucial on our scientific path to discovery.

John Mulligan, CEO and Founder

Join Us

Bonum Therapeutics is seeking scientists with experience in cancer immunology, protein engineering, molecular biology, protein sciences, or assay development to join us in our quest for safer and more effective therapeutics.

Careers